Evidence map›Paper›PMID 42897429›Full record

ReviewCognitive, affective & behavioral neuroscience2026

Orbitofrontal-ventral striatal coupling: A model of the neurobehavioral architecture of craving in substance use disorders.

Reza Maleeh

Abstract readReview
PubMed Publisher
In one paragraph

Review in Cognitive, affective & behavioral neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Reza MaleehSchool of Historical and Philosophical Inquiry, The University of Queensland, Brisbane, St Lucia, QLD, 4072, Australia. rezamaleeh1@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuroimaging has identified cue-elicited activity in ventral striatum and orbitofrontal cortex (OFC) as a reliable signature of craving, yet activation magnitude in either region is an inconsistent predictor of clinical outcome. This theoretical review develops a model on which the clinically consequential variable is not activation but effective coupling: the cue-evoked gain-the factor by which an input is amplified-with which OFC valuation signals modulate ventral striatal action-selection activity. I formalize this gain as valuation-policy coupling (λ), which governs the probability that a drug-related appraisal recruits approach and consumption policies; it is a latent construct indexed by effective OFC-accumbens connectivity, approach bias under load, and pharmacological challenge. Two moderators-meta-awareness and elaborative versus nonelaborative engagement-determine whether the urge is re-entered or exited, and jointly specify a neurocognitive space in which craving occupies a high-λ, high-meta-awareness, elaborative vertex. The framework predicts an awareness-amplification effect-noticing an urge intensifies it under high λ and weakens it under low λ-specifies when mindfulness-based relapse prevention should attenuate craving and when it should not, and yields a discriminative prediction: λ-reducing interventions should reduce cue-modulated OFC-ventral-striatum coupling while leaving regional activation comparatively preserved. λ is a parameter of craving rather than of relapse-which also requires cognitive-control parameters-and a candidate transdiagnostic mechanism. Claims are labeled by evidential status; the λ-meta-awareness interaction is the model's principal hypothesis, and failure conditions are stated explicitly.

Indexed as

CravingEffective connectivityMeta-awarenessMindfulness-based relapse preventionOrbitofrontal cortexVentral striatum

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.